Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Efficacy & Outcomes of Intra-vitreal Ranibizumab Injection in the Treatment of Aggressive Posterior Retinopathy of Prematurity

NCT07721298 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT07721298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07721298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Efficacy & Outcomes of Intra-vitreal Ranibizumab Injection in the Treatment of Aggressive Posterior Retinopathy of Prematurity
Lead sponsor
Ain Shams University
Phase
Not applicable
Overall status
Completed
Start date
September 10, 2021
Completion date
February 1, 2025
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

retinopathy of prematurity (rop)